West Nile Virus (WNV) Molecular Detection
Synonyms |
|
||||||||||||
Cerner Name |
|||||||||||||
Clinical Info |
The direct detection of WNV is a valuable tool in determining whether a patient is infected with West Nile virus. PCR is able to detect WNV RNA directly and does not rely on antibody markers of WNV infection, which are produced after RNA is detectable in newly infected individuals. |
||||||||||||
Specimen Sources |
Blood, Venous Lumbar Puncture |
||||||||||||
Specimen Types |
Blood Cerebrospinal Fluid |
||||||||||||
Specimen Volume |
1 mL plasma or serum ( 0.5 mL min) |
||||||||||||
Container |
CSF Tube |
||||||||||||
Collection Instructions |
Submit one of the following: |
||||||||||||
Transport Instructions |
Frozen |
||||||||||||
Specimen Stability |
8 hours Room Temperature |
||||||||||||
Methodology |
Qualitative polymerase chain reaction (PCR) |
||||||||||||
Days Performed |
Monday - Friday |
||||||||||||
Performing Laboratory |
ARUP Laboratories |
||||||||||||
CPT |
87798 |
||||||||||||
PDM |
1459868 |
||||||||||||
Only Orderable at Locations: |
Orderable Everywhere |
||||||||||||
Results |
|
||||||||||||
Result Interpretation
Not Detected
This test was developed and its performance characteristics determined by ARUP Laboratories. The U. S. Food and Drug Administration has not approved or cleared this test; however, FDA clearance or approval is not currently required for clinical use. The results are not intended to be used as the sole means for clinical diagnosis or patient management decisions |
|||||||||||||
Forms |
|